12-59774921-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001270623.2(SLC16A7):āc.626A>Gā(p.Asn209Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000039 in 1,613,902 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001270623.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SLC16A7 | NM_001270623.2 | c.626A>G | p.Asn209Ser | missense_variant | 5/6 | ENST00000547379.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SLC16A7 | ENST00000547379.6 | c.626A>G | p.Asn209Ser | missense_variant | 5/6 | 1 | NM_001270623.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152208Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000319 AC: 8AN: 250504Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135472
GnomAD4 exome AF: 0.0000363 AC: 53AN: 1461694Hom.: 1 Cov.: 33 AF XY: 0.0000344 AC XY: 25AN XY: 727138
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152208Hom.: 0 Cov.: 32 AF XY: 0.0000672 AC XY: 5AN XY: 74352
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 07, 2022 | The c.626A>G (p.N209S) alteration is located in exon 4 (coding exon 3) of the SLC16A7 gene. This alteration results from a A to G substitution at nucleotide position 626, causing the asparagine (N) at amino acid position 209 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at